Immunology Innovation

IIP Spotlight: Working Together To Tackle Asthma

In collaboration with argenx, Dr. Lambrecht kickstarted a journey to develop a potential treatment for asthma and airway inflammation. He uncovered the immunology breakthrough that allergic airway inflammation is a crystallopathy caused by Charcot-Leyden crystals (CLCs), which he observed in the airway of severe asthmatics.

Discover Related Stories

Explore more about work to chart a new course in immunology
Immunology Innovation
What is FcRn? And Could blocking FcRn redefine the treatment of dozens of autoimmune diseases?

Interested in Learning More?

Get argenx news and updates right to your inbox


Download assets
Get photos, fact sheets, illustrations and more.
Join the team
Dare to do more with a thriving career at argenx.
Follow us
Get the latest news and info via our social media channels.